Europe, the Middle East and Africa Diabetes Pen Market- Forecast to 2032

Table of Contents

1 Introduction

1.1 Definition

1.2 Scope of the study

1.2.1 Research Objectives

1.2.2 Assumptions & Limitations

1.3 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

2.4 Forecast Model

3 Report Excerpt

4 Forecast Indicators

4.1 Introduction

4.2 Growth Drivers

4.3 Growth Barriers

4.5 Macroecnomical Indicators

5 Market Analysis

5.1 Porter's Five Force

5.2 Supply Chain Analysis

6 Europe, the Middle East and Africa Diabetes Pen Market, by Type

6.1 Disposable Insulin Pen

6.2 Reusable Insulin Pen

7 Europe, the Middle East and Africa Diabetes Pen Market, by Therapy

7.1 Insulin

7.2 Glucagon-Like Peptide-1 (Glp-1)

7.3 Growth Hormones

8 Europe, the Middle East and Africa Diabetes Pen Market, by Region

8.1 Introduction

8.2 EUROPE

8.2.1 GERMANY

8.2.2 FRANCE

8.2.3 U.K.

8.2.4 ITALY

8.2.5 SPAIN

8.2.6 Russia

8.3.7 REST OF EUROPE

8.3 Middle East & Africa

9 Competitive Landscape

9.1 Market Share Analysis

9.2 Competitive/Strategic Scenario

9.2.1 Mergers Acquisitions

9.2.2 Collaborations

9.2.3 Expansion

9.2.4 New Product Launches

10 Company Profiles

10.1 Becton, Dickinson And Company

10.2 Novo Nordisk A/S

10.3 Ypsomed Holding Ag

10.4 Owen Mumford, Ltd.

10.5 Sanofi

10.6 Eli Lilly

10.7 Merck Animal Health